Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in heavy menstrual bleeding
NCT00113568Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2005
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tranexamic acid in Menorrhagia, sponsored by Ferring Pharmaceuticals. Primary endpoints: Number of Subjects With at Least One Adverse Event During the Study at 108 weeks, Number of Subjects With at least One Possibly Treatment-Related Adverse Event During the Study at 108 weeks and 7 more. Started Jun 2005; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Menorrhagia
Beyond the preview
Go deeper on NCT00113568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113568.